Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan R Hauser

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Critical Care Medicine|December 19, 2013
Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?Alan R Hauser
Msystems|March 23, 2026
<i>Pseudomonas aeruginosa</i> strains lack tissue specificityAlan R Hauser
Critical Care Medicine|July 20, 2012
Ventilator-associated pneumonia caused by Pseudomonas aeruginosa: cap your needles!Alan R Hauser
American Journal of Respiratory and Critical Care Medicine|August 21, 2008
Pseudomonas aeruginosa: an uninvited guest refuses to leaveAlan R Hauser
Nature Reviews. Microbiology|August 15, 2009
The type III secretion system of Pseudomonas aeruginosa: infection by injectionAlan R Hauser
Critical Care Medicine|August 19, 2011
Pseudomonas aeruginosa: so many virulence factors, so little timeAlan R Hauser
Postgraduate Medicine|January 28, 2005
Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistanceAlan R Hauser, Padman Sriram
Infection and Immunity|November 24, 2004
Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lungCiara M Shaver, Alan R Hauser
Journal of Bacteriology|May 1, 2019
Diversity of Contact-Dependent Growth Inhibition Systems of <i>Pseudomonas aeruginosa</i>Jonathan P Allen, Alan R Hauser
Infection and Immunity|May 30, 2013
Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoUGregory H Tyson, Alan R Hauser
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Critical Care Medicine|December 19, 2013
Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?Alan R Hauser
Msystems|March 23, 2026
<i>Pseudomonas aeruginosa</i> strains lack tissue specificityAlan R Hauser
Critical Care Medicine|July 20, 2012
Ventilator-associated pneumonia caused by Pseudomonas aeruginosa: cap your needles!Alan R Hauser
American Journal of Respiratory and Critical Care Medicine|August 21, 2008
Pseudomonas aeruginosa: an uninvited guest refuses to leaveAlan R Hauser
Nature Reviews. Microbiology|August 15, 2009
The type III secretion system of Pseudomonas aeruginosa: infection by injectionAlan R Hauser
Critical Care Medicine|August 19, 2011
Pseudomonas aeruginosa: so many virulence factors, so little timeAlan R Hauser
Postgraduate Medicine|January 28, 2005
Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistanceAlan R Hauser, Padman Sriram
Infection and Immunity|November 24, 2004
Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lungCiara M Shaver, Alan R Hauser
Journal of Bacteriology|May 1, 2019
Diversity of Contact-Dependent Growth Inhibition Systems of <i>Pseudomonas aeruginosa</i>Jonathan P Allen, Alan R Hauser
Infection and Immunity|May 30, 2013
Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoUGregory H Tyson, Alan R Hauser
Pageof 13